GlassScriptPhysician profile
Kevin L Sullivan
NPI 1245390897
$2,385.13
in general payments reported to CMS, 2019-2025
16 companies · $385 in 2025
The $385 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.84 · 2020: $17.37 · 2021: $81.99 · 2022: $176 · 2023: $1,566 · 2024: $63.40 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,250 · Food and Beverage: $765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,250.00 |
| Food and Beverage | $764.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $1,250.00 | 2023 | Visumax |
| Alcon Vision LLC | $625.96 | 2019-2025 | Clareon, Argos, Hydrus Microstent |
| Harrow Eye, LLC | $123.94 | 2025 | Vevye |
| Novartis Pharmaceuticals Corporation | $70.20 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $65.21 | 2022-2025 | Envista Envy Iol, Infuse |
| Allergan, INC. | $41.77 | 2021 | |
| Abbvie INC. | $35.92 | 2022 | |
| Oyster Point Pharma, INC. | $27.87 | 2022 | |
| Rayner Intraocular Lenses Limited | $24.76 | 2025 | Omidria |
| Aerie Pharmaceuticals, INC. | $23.34 | 2021 | |
| Amgen INC. | $22.50 | 2025 | Tepezza |
| Thea Pharma INC. | $19.10 | 2025 | Iyuzeh |
| Beaver-Visitec International, INC. | $18.99 | 2023 | |
| Kyowa Kirin, INC. | $17.73 | 2025 | |
| Astellas Pharma US INC | $16.63 | 2024 | Izervay |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $1.21 | 2024 | Ahmed Glaucoma Valve, Kahook Dual Blade, Streamline |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.